Dr. Suresh Kumar. B

About the Doctor

<div><b>Designation:</b> Associate Consultant - Medical Oncology</div>
<div><b>Education:</b></div>
<ul>
<li>MBBS - Government Chengalpattu Medical College</li>
<li>MD in Internal Medicine - Madurai Medical College</li>
<li>DM Medical Oncology - Tata Memorial Hospital, Mumbai</li>
<li>DrNB Medical Oncology - National Board of Examinations in medical sciences, New Delhi. </li>
<li>ACORD Fellow - Sydney Australia.</li>
<li>OCTT (Oncology Clinical Trials training)</li>
<li>European Certified Medical Oncologist (ECMO)</li>
<li>MRCP SCE (UK)(Medical Oncology)</li>
<li>CCEPC - Indian Association of Palliative care, New Delhi </li>
</ul>
<div><b>Brief Profile:</b>Passionate medical oncologist with 5 years of experience at the premier institute of oncology in India - Tata Memorial Centre, Mumbai, with focused interest in targeted therapy and immunotherapy.</div>
<div><b>Areas of Specialisation:</b></div>
<ul>
<li>Head &amp; Neck Malignancies</li>
<li>Breast Malignancies</li>
<li>Thoracic Malignancies</li>
<li>Gastrointestinal Malignancies</li>
<li>Gynec Malignancies</li>
<li>Urological malignancies </li>
<li>Precision &amp; Molecular Oncology</li>
<li>lmmunotherapy, Targeted therapy, Hormonal therapy &amp; Chemotherapy</li>
<li>Clinical trials &amp; Research</li>
<li>Bone Marrow and  Stem Cell Transplant</li>
<li>Palliative Therapy</li>
</ul>
<div><b>Awards and achievements</b></div>
<ul>
<li>"Best Outgoing Student of MBBS batch", awarded in the year 2014, by Chengalpattu medical college. </li>
<li>"Dr. Muthusethupathy Gold Medal in MD" awarded by the Department of Nephrology, Madras medical college for securing the first prize in the state level medal exam. </li>
<li>Secured Distinctions in several subjects in MBBS and MD </li>
</ul>
<div><b>Research activities and Paper publication</b></div>
<ul>
<li>Conducted research on "Sarcomatoid Carcinoma of Lung" from 2019-2020, in Department of Medical Oncology, Tata Memorial hospital, Mumbai.  </li>
<li>Conducted research on "Safety and Efficacy of Generic Pomalidomide" from 2017 - 2020, in Department of Medical Oncology, Tata Memorial hospital, Mumbai. </li>
<li>Conducting a phase II clinical trial on "Role of Maintenance Lenalidomide In Primary CNS Lymphoma" in Department of Medical Oncology, Tata Memorial hospital, Mumbai.</li>
<li>Published 30+ papers in reputed national and international journals. </li>
</ul>